A carregar...
An Update on SGLT2 Inhibitors for the Treatment of Diabetes Mellitus
PURPOSE OF REVIEW: SGLT2 inhibitors are the newest class of oral anti-hyperglycemic agents that have been approved for the treatment of diabetes mellitus. Over the past year there have been significant developments in both the safety and efficacy of this class of medications that are presented in th...
Na minha lista:
| Publicado no: | Curr Opin Endocrinol Diabetes Obes |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6028052/ https://ncbi.nlm.nih.gov/pubmed/27898586 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MED.0000000000000311 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|